Skip to content

Effect of Agonist Contract Relax Versus Antagonist Contract Relax in Chronic Stroke Patient.

Effect of Agonist Contract Relax Versus Antagonist Contract Relax Technique on Spasticity and Ankle Range of Motion in Chronic Stroke Patient.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05957731
Enrollment
112
Registered
2023-07-24
Start date
2022-11-07
Completion date
2023-07-30
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Agonist contract relax, antagonist contract relax, stretching, modified A

Brief summary

It will be a randomized control trial with 112 patients which will be divided into two groups of 56 patients in each group. Participants will recruit through convenient sampling techniques. Outcome measures are range of motion and spasticity. The protocol was implemented three days per week for eight consecutive weeks. Data will be collected at baseline and 8 th week after intervention.

Detailed description

Objective of the study is to compare the effects of the agonist contract-relax technique versus the antagonist contract-relax technique on spasticity and range of motion in individuals with chronic stroke. Null hypothesis (H0): There are no comparative effects of agonist contact-relax technique and the antagonist contract-relax technique on spasticity and ankle range of motion in chronic patients. The alternate hypothesis (HA): There are comparative effects of agonist contract-relax technique and the antagonist contract-relax technique on spasticity and ankle range of motion in chronic stroke patients. The sample size came out to 94 (47 in each group) after adding 20% dropout the sample size was 47+9=56 in each group.

Interventions

OTHERRoutine physical therapy

Both groups received routine physical therapy, which encompasses various components such as electrotherapy, strength training for both lower and upper limbs, gait training, and occupational therapy.

OTHERantagonist contract relax

antagonist contraction i used to improve spasticity and range of motion in stroke patients

OTHERagonist contract relax

agonist contraction is used to improve spasticity and range of motion in stroke patients

Sponsors

University of Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients with a confirmed diagnosis of stroke by a neurologist. * Inclusion of patients with both ischemic and hemorrhagic stroke. * Both male and female patients are eligible. * Age range between 40 to 60 years. * Modified Ashworth Scale ranging from 0 to 2. * Minimum muscle strength grade of 3

Exclusion criteria

* History of surgery on lower limb * Who received injection therapies for reducing spasticity * Lower extremity contracture * Modified Ashworth scale of 3-4

Design outcomes

Primary

MeasureTime frameDescription
Modified Ashworth Scale.it will measure change in spasticity at baseline and at 8th weekThe assessment involves extending the limb of the parent from a state of utmost flexion to utmost extension, identifying the point at which initial mild resistance was encountered. Following that, the modified Ashworth Scale is employed while transitioning the limb from extension to flexion. Interrater reliability studies utilizing the MAS have yielded varied results, ranging from moderate to good.
universal goniometerit will measure change in range of motion at baseline and at 8th weekThe universal goniometer (UG) is a widely employed tool for assessing range of motion.Range of motion refers to the complete extent of movement possible at a specific joint. In a normal ankle, the range of motion typically spans from around 20ºof dorsiflexion to 50º of plantar flexion. For normal walking, a combined motion of approximately 24º to 30º (including both dorsiflexion and plantar flexion) is required.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026